AMERIPATH REPORTS RECORD YEAR & LOSES ITS CHAIRMAN MIXED SIGNALS RECENTLY EMERGED from AmeriPath, Inc., the country’s largest pathology PPM. It finished the year with strong financials and lost its chairman. On one hand, it finished its first full year as a public company with strong revenue growth and adequate profits. As CEO James New […]
- "Lab Industry Briefs"
AmeriPath, Cytyc, NeoPath, Morphometrix, AutoCyte
- By Robert Michel
- > From the Volume VI No. 4 - March 15, 1999 Issue
